Ditchcarbon
  • Customers
  1. Organizations
  2. Akorn
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 4 days ago

Akorn

Company website

Akorn, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 1971, the company has established itself as a leader in the development, manufacturing, and marketing of specialty pharmaceuticals, particularly in the areas of ophthalmology, anaesthesia, and injectables. With a diverse portfolio of products, Akorn is recognised for its commitment to quality and innovation, offering unique formulations that cater to specific patient needs. The company has achieved significant milestones, including the expansion of its manufacturing capabilities and a robust pipeline of generic and branded medications. Akorn's strategic focus on niche markets has solidified its position as a trusted provider in the competitive pharmaceutical landscape.

DitchCarbon Score

How does Akorn's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Akorn's score of 29 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

54%

Let us know if this data was useful to you

Akorn's reported carbon emissions

As of the latest available data, Akorn has not reported any specific carbon emissions figures in kg CO2e. However, the company has established significant climate commitments aimed at achieving net-zero carbon emissions. Akorn's near-term target mandates that new buildings must be net-zero carbon emitters by 2030, while existing buildings are expected to meet this standard by 2050. These initiatives are part of a broader strategy to align with impending policy interventions in the property sector, particularly in markets such as the United Kingdom. The company's commitments focus on Scope 1 emissions, indicating a proactive approach to reducing direct emissions from owned or controlled sources. While specific reduction percentages have not been disclosed, the long-term vision reflects a commitment to sustainability and environmental responsibility. Overall, Akorn's climate initiatives demonstrate a forward-thinking approach to carbon management, although detailed emissions data and specific reduction targets remain unavailable at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Akorn's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Akorn is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Akorn is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

ANI Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Sucampo Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Accord Healthcare Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 minutes ago

Ironwood Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250915.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy